Iannone Robert's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Aug 31, 2026
- Accession no.
- 0001737329-26-000016
- Filed
- Aug 31, 2026, 6:45 PM ET
- Trade date
- Aug 27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $19.2M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Iannone RobertCIK 0001737329 | Officer (EVP, Global Head of R&D & CMO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ordinary Shares | MOption exerciseAcquired | +26,116 | $113.10 | +$2,953,719.6 | 111,223 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseAcquired | +884 | $113.10 | +$99,980.4 | 112,107 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseAcquired | +27,584 | $137.12 | +$3,782,318.08 | 139,691 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseAcquired | +2,916 | $137.12 | +$399,841.92 | 142,607 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −18,187 | $247.86F2 | −$4,507,780.72 | 124,420 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −11,423 | $248.67F3 | −$2,840,516.29 | 112,997 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −18,113 | $250.02F4 | −$4,528,572.41 | 94,884 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −19,639 | $250.60F5 | −$4,921,596.24 | 75,245 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −9,259 | $251.95F6 | −$2,332,804.12 | 65,986 | Direct | |
| Aug 27, 2026 | Ordinary Shares | SSaleDisposed | −300 | $252.76 | −$75,828 | 65,686 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ordinary Shares | MOption exerciseDisposed | −884 | $0.00 | $0 | 0 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseDisposed | −2,916 | $0.00 | $0 | 0 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseDisposed | −26,116 | $0.00 | $0 | 0 | Direct | |
| Aug 27, 2026 | Ordinary Shares | MOption exerciseDisposed | −27,584 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $247.29 to $248.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F3
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $248.29 to $249.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $249.33 to $250.325 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $250.33 to $251.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.
- F6
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $251.37 to $252.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.